Sign inJoin waitlistJoin the waitlist

Terry Burns

Associate Program Director, Neurosurgical Oncology Fellowship · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Neurosurgical Oncology Fellowship · Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Neurological Surgery
Stanford University
2009–2016
Univ of Minnesota, Duluth Sch of Med
2005–2009
Columbia Union College
2001–2005

Research

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Review · Neuro-Oncology · 2018 · 581 citations
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Cell Metabolism · 2019 · 401 citations
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Neuro-Oncology · 2020 · 223 citations

Ian Parney
38 papers
Sani Kizilbash
28 papers
Ugur Sener
19 papers
Michael Ruff
16 papers
Desmond Brown
15 papers · 7 as a fellow
CG
Caterina Giannini
14 papers
Daniel Lachance
14 papers
Jann Sarkaria
14 papers
Lucas Carlstrom
14 papers · 14 as a resident
Alfredo Quinones-Hinojosa
13 papers
Robert Jenkins
13 papers
Jian Campian
12 papers

Grants

Individualized DNA Junctions for Glioma Response Assessment via Longitudinal Liquid Biopsies
National Cancer Institute · R01
Contact PI · $565.4K · Mayo Clinic Rochester
2026–2031
Assay Validation of Cell-Free DNA Amplified DNA Junctions for High Grade Glioma Monitoring
National Cancer Institute · UH3
PI · $402.7K · Mayo Clinic Rochester
2025–2029
Augmenting Immunotherapy Pharmacodynamics in Glioma
National Institute of Neurological Disorders and Stroke · UG3
Contact PI · $712.8K · Mayo Clinic Rochester
2026–2028
Glioma Intelligence from Behind Enemy Lines
National Cancer Institute · R37
Contact PI · $2.1M · Mayo Clinic Rochester
2023–2028

Clinical trials

A Study for Cerebral Open Flow Microperfusion
Principal investigator · Not yet recruiting
Mayo Clinic
2026–2028
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Principal investigator · Recruiting · Phase 1, Phase 2
Mayo Clinic
2026–2030
Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
Principal investigator · Withdrawn · Phase 1
Mayo Clinic
2025
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Principal investigator · Recruiting · Early phase 1
Mayo Clinic
2025–2031